Paper39740933
Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis.
Rademacher J and 8 others. RMD Open, 2024. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis. Papers, record 39740933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39740933
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Leukocyte L1 Antigen Complex | Major topic |
| Haptoglobins | Major topic |
| Protein Precursors | Major topic |
| Tumor Necrosis Factor Inhibitors | Major topic |
| Axial Spondyloarthritis | Major topic |
| Humans | |
| Female | |
| Male | |
| Adult | |
| Middle Aged | |
| Acute-Phase Proteins | |
| Membrane Glycoproteins | |
| Carrier Proteins | |
| Cholera Toxin | |
| Severity of Illness Index | |
| Treatment Outcome | |
| Case-Control Studies | |
| Bacterial Translocation | |
| Lipopolysaccharide-Binding Protein |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29453216 | Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. | Ann Rheum Dis | 2018 | https://conductscience.org/library/papers/29453216 | PubMed |
| 2 | 37280714 | Increased gut permeability and intestinal inflammation precede arthritis onset in the adjuvant-induced model of arthritis. | Arthritis Res Ther | 2023 | https://conductscience.org/library/papers/37280714 | PubMed |
| 3 | 27055115 | Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis. | PLoS One | 2016 | https://conductscience.org/library/papers/27055115 | PubMed |
| 4 | 31563879 | Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity. | Gut | 2020 | https://conductscience.org/library/papers/31563879 | PubMed |
| 5 | 1698311 | CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. | Science | 1990 | https://conductscience.org/library/papers/1698311 | PubMed |
| 6 | 28850019 | Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis. | Clin Exp Rheumatol | 2018 | https://conductscience.org/library/papers/28850019 | PubMed |
| 7 | 30175641 | Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment. | Mod Rheumatol | 2019 | https://conductscience.org/library/papers/30175641 | PubMed |
| 8 | 10801176 | Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. | Lancet | 2000 | https://conductscience.org/library/papers/10801176 | PubMed |
| 9 | 34560894 | Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint. | Arthritis Res Ther | 2021 | https://conductscience.org/library/papers/34560894 | PubMed |
| 10 | 29459849 | Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/29459849 | PubMed |
| 11 | 2427635 | Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. | J Exp Med | 1986 | https://conductscience.org/library/papers/2427635 | PubMed |
| 12 | 7699630 | A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. | J Rheumatol | 1994 | https://conductscience.org/library/papers/7699630 | PubMed |
| 13 | 30573517 | Intraindividual Variation in Markers of Intestinal Permeability and Adipose Tissue Inflammation in Healthy Normal-Weight to Obese Adults. | Cancer Epidemiol Biomarkers Prev | 2019 | https://conductscience.org/library/papers/30573517 | PubMed |
| 14 | 29656372 | Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. | Clin Rheumatol | 2018 | https://conductscience.org/library/papers/29656372 | PubMed |
| 15 | 32606474 | Biomarker development for axial spondyloarthritis. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32606474 | PubMed |
| 16 | 32661321 | Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32661321 | PubMed |
| 17 | 30640940 | Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. | PLoS One | 2019 | https://conductscience.org/library/papers/30640940 | PubMed |
| 18 | 26698844 | Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/26698844 | PubMed |
| 19 | 8835560 | The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. | J Rheumatol | 1995 | https://conductscience.org/library/papers/8835560 | PubMed |
| 20 | 38706167 | Immunological biomarkers in patients with radiographic axial spondyloarthritis, an exploratory longitudinal Swedish study. | Mod Rheumatol | 2024 | https://conductscience.org/library/papers/38706167 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42529164 | Gut microbiota and intestinal permeability in rheumatoid arthritis: pathogenic mechanisms. | Front Immunol | 2026 | https://conductscience.org/library/papers/42529164 | PubMed |
| 41972162 | Association between intestinal permeability, systemic inflammation, and response to anti-TNF therapy in patients with rheumatoid arthritis: a prospective controlled study. | Front Immunol | 2026 | https://conductscience.org/library/papers/41972162 | PubMed |
| 41752805 | Evaluation of Serum Calprotectin Levels and Their Relationship with Disease Activity in Psoriatic Arthritis and Axial Spondyloarthritis. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41752805 | PubMed |
| 40904690 | Gut microbiota and ankylosing spondylitis: current insights and future challenges. | Microb Cell | 2025 | https://conductscience.org/library/papers/40904690 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| HP | 3240 | PubTator's text mining | https://conductscience.org/library/genes/3240 | NCBI Gene |
| LBP | 3929 | PubTator's text mining | https://conductscience.org/library/genes/3929 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39740933
GET https://conductscience.org/api/papers/v1/39740933/references?page=2